As Vice Chancellor for Health Affairs and Dean of the School of Medicine at the University of California at Irvine, Dr. Federoff has oversight for the clinical, medical educational, and research missions. He is currently the acting CEO for UCI Health. Prior to UCI, Dr. Federoff was the Executive Vice President for Health Sciences at Georgetown University and Executive Dean of the School of Medicine. He is a professor of Neurology. Prior to Georgetown, he held appointments as Senior Associate Dean; Professor of Neurology, Medicine, Microbiology and Immunology; and Professor of Oncology and Genetics at the University of Rochester School of Medicine, and as Founding Director of the Center for Aging and Development Biology at the Aab Institute of Biomedical Sciences and Founding Division Chief of Molecular Medicine and Gene Therapy. Dr. Federoff’s research interests include gene therapy and neurodegenerative diseases. He has published greater than 250 peer review and invited articles and serves as a reviewer for many journals, and currently serves on the editorial boards of five journals. Dr. Federoff served as Chair of the NIH Recombinant DNA Advisory Committee from 2007-2010. He Chairs the Gene Therapy Resource Program for NHLBI, was President of the American Society for Neural Therapy and Repair (2012-2013) and is President of the American Society for Experimental Neurotherapeutics (2014-2016). Dr. Federoff received his MS, PhD, and MD degrees from the Albert Einstein College of Medicine, did his internship, residency, and clinical and research fellowships at Massachusetts General Hospital/Harvard Medical School, practiced medicine at MGH, Albert Einstein and Strong Memorial Hospital at the University of Rochester. He is a Fellow of the AAAS and National Academy of Inventors.